A detailed history of Gateway Investment Advisers LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 547,589 shares of ABT stock, worth $62.7 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
547,589
Previous 548,162 0.1%
Holding current value
$62.7 Million
Previous $57 Million 9.61%
% of portfolio
0.69%
Previous 0.65%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$100.07 - $118.13 $57,340 - $67,688
-573 Reduced 0.1%
547,589 $62.4 Million
Q2 2024

Jul 12, 2024

SELL
$100.73 - $112.44 $307,629 - $343,391
-3,054 Reduced 0.55%
548,162 $57 Million
Q1 2024

Apr 12, 2024

SELL
$109.52 - $120.96 $1.55 Million - $1.72 Million
-14,185 Reduced 2.51%
551,216 $62.7 Million
Q4 2023

Jan 09, 2024

BUY
$90.19 - $110.4 $167,663 - $205,233
1,859 Added 0.33%
565,401 $62.2 Million
Q3 2023

Oct 19, 2023

SELL
$95.53 - $114.62 $23,309 - $27,967
-244 Reduced 0.04%
563,542 $54.6 Million
Q2 2023

Jul 13, 2023

SELL
$100.78 - $112.29 $25,195 - $28,072
-250 Reduced 0.04%
563,786 $61.5 Million
Q1 2023

Apr 11, 2023

SELL
$96.86 - $114.01 $3.96 Million - $4.66 Million
-40,882 Reduced 6.76%
564,036 $57.1 Million
Q4 2022

Jan 13, 2023

BUY
$95.06 - $111.52 $399,061 - $468,160
4,198 Added 0.7%
604,918 $0
Q3 2022

Oct 07, 2022

SELL
$96.76 - $112.03 $576,979 - $668,034
-5,963 Reduced 0.98%
600,720 $58.1 Million
Q2 2022

Jul 13, 2022

BUY
$102.07 - $123.37 $223,022 - $269,563
2,185 Added 0.36%
606,683 $65.9 Million
Q1 2022

Apr 14, 2022

SELL
$114.02 - $139.04 $1.98 Million - $2.42 Million
-17,370 Reduced 2.79%
604,498 $71.5 Million
Q4 2021

Jan 14, 2022

SELL
$115.53 - $141.46 $1.69 Million - $2.07 Million
-14,640 Reduced 2.3%
621,868 $87.5 Million
Q3 2021

Oct 22, 2021

BUY
$116.66 - $129.06 $50,863 - $56,270
436 Added 0.07%
636,508 $75.2 Million
Q2 2021

Jul 13, 2021

SELL
$105.79 - $124.53 $2.53 Million - $2.97 Million
-23,885 Reduced 3.62%
636,072 $73.7 Million
Q1 2021

Apr 14, 2021

SELL
$108.84 - $128.23 $1.13 Million - $1.33 Million
-10,380 Reduced 1.55%
659,957 $79.1 Million
Q4 2020

Jan 14, 2021

SELL
$105.0 - $114.42 $6.11 Million - $6.66 Million
-58,182 Reduced 7.99%
670,337 $73.4 Million
Q3 2020

Oct 19, 2020

SELL
$91.64 - $111.29 $5.49 Million - $6.67 Million
-59,928 Reduced 7.6%
728,519 $79.3 Million
Q2 2020

Jul 15, 2020

SELL
$76.57 - $98.0 $4.37 Million - $5.59 Million
-57,046 Reduced 6.75%
788,447 $72.1 Million
Q1 2020

Apr 13, 2020

SELL
$62.82 - $91.86 $6.75 Million - $9.86 Million
-107,376 Reduced 11.27%
845,493 $66.7 Million
Q4 2019

Jan 09, 2020

SELL
$78.51 - $87.4 $671,260 - $747,270
-8,550 Reduced 0.89%
952,869 $82.8 Million
Q3 2019

Oct 15, 2019

SELL
$81.84 - $88.74 $4.17 Million - $4.53 Million
-50,992 Reduced 5.04%
961,419 $80.4 Million
Q2 2019

Jul 17, 2019

SELL
$72.88 - $85.0 $98,242 - $114,580
-1,348 Reduced 0.13%
1,012,411 $85.1 Million
Q1 2019

Apr 10, 2019

SELL
$66.22 - $80.06 $278,124 - $336,252
-4,200 Reduced 0.41%
1,013,759 $81 Million
Q4 2018

Jan 14, 2019

BUY
$65.56 - $74.27 $256,667 - $290,767
3,915 Added 0.39%
1,017,959 $73.6 Million
Q3 2018

Oct 16, 2018

SELL
$60.81 - $73.36 $105,748 - $127,573
-1,739 Reduced 0.17%
1,014,044 $74.4 Million
Q2 2018

Jul 11, 2018

SELL
$57.57 - $63.54 $468,677 - $517,279
-8,141 Reduced 0.8%
1,015,783 $62 Million
Q1 2018

Apr 12, 2018

BUY
$56.27 - $63.62 $3.77 Million - $4.26 Million
66,999 Added 7.0%
1,023,924 $61.4 Million
Q4 2017

Jan 17, 2018

SELL
$53.68 - $57.47 $7.31 Million - $7.82 Million
-136,100 Reduced 12.45%
956,925 $54.6 Million
Q3 2017

Oct 16, 2017

BUY
$48.06 - $53.64 $52.5 Million - $58.6 Million
1,093,025
1,093,025 $58.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.